Boston Scientific Cross-Appeals Stent Patent Ruling

Law360, New York (March 3, 2010, 2:15 PM EST) -- Weeks after Johnson & Johnson Inc. appealed a federal court's ruling that four of its patents for drug-eluting stents are invalid, Boston Scientific Corp. has notified the court that it will also appeal parts of that case.

BSC lodged a notice of cross-appeal Tuesday in the U.S. District Court for the District of Delaware, saying it would ask the U.S. Court of Appeals for the Federal Circuit to reconsider all underlying opinions, orders and rulings adverse to BSC, including certain claim limitations construed in a Jan....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.